3-amino-6-methyl-5-phenyl-2(1h)-pyridinone has been researched along with amrinone in 2 studies
| Studies (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Trials (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Recent Studies (post-2010) (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Studies (amrinone) | Trials (amrinone) | Recent Studies (post-2010) (amrinone) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 834 | 78 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Herzig, JW; Quast, U | 1 |
1 review(s) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and amrinone
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
1 other study(ies) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and amrinone
| Article | Year |
|---|---|
On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents.
Topics: Amrinone; Animals; Bepridil; Calcium; Calcium-Binding Proteins; Calmodulin; Cardiotonic Agents; Dose-Response Relationship, Drug; Milrinone; Models, Cardiovascular; Myocardial Contraction; Piperazines; Pyridones; Swine; Trifluoperazine; Troponin; Troponin C | 1992 |